← All indications
Xerostomia
Decreased salivary flow.
Subtype terms (1)
More specific conditions that are subtypes of Xerostomia in the MeSH hierarchy.
- Sjogren's Syndrome
131 drugs (54 approved, 77 experimental)
Drugs by status
Approved for this indication (4)
Phase 4 trials (5)
Phase 3 trials (9)
Phase 2 trials (27)
- thalidomide
- urea
- bioxtra
- dehydroepiandrosterone
- paclitaxel
- ngx267
- p-552
- surfactant
- carboplatin
- dipyridamole
- stem cells
- aav2haqp1
- autologous bone marrow derived mesenchymal cells
- autologous stromal vascular fraction
- stromal vascular fraction
- autologous mesenchymal stem cells
- rituximab
- oxygen
- a. digitata
- m. sylvestris
- cisplatin
- rebamipide
- selenomethionine se-75
- onabotulinumtoxinA
- autologous adipose-derived mesenchymal stem cells
- spermidine
- rxrg001
Phase 1 trials (9)
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (16)
- Schering-Plough
- National Cancer Institute (NCI)
- Cairo University
- CancerCare Manitoba
- McGill University
- McMaster University
- NRG Oncology
- Radiation Therapy Oncology Group
- University of Ottawa
- Groupe Oncologie Radiotherapie Tete et Cou
- University of Calgary
- Notre-Dame Hospital, Paris
- Humboldt University
- University of Granada
- Newfoundland Cancer Treatment & Research Foundation
- Universidad Carlos III Madrid
Organization Involved with Phase 2 Indications (30)
- Acacia Pharma Ltd
- AstraZeneca
- MedImmune
- Parion Sciences
- TorreyPines Therapeutics
- Otsuka
- National Institute of Dental and Craniofacial Research (NIDCR)
- Shahid Beheshti University of Medical Sciences
- University of Pennsylvania
- Azad University
- University of London
- Harvard University
- Institut de Terapia Regenerativa Tissular
- University of Rostock
- University of Tehran
- Cyprus University of Technology
- Imam Khomeini Hospital
- Midwestern Regional Medical Center
- Qazvin University Of Medical Sciences
- University of Copenhagen
- Vanderbilt University
- Altoona Center for Clinical Research
- Martin Luther University
- State University of New York, Buffalo
- Walter F. Chase MD. PA
- KhonKaen University
- Ubonratchathani Cancer Hospital
- General Drug House Ltd., Bangkok
- Verband Deutscher Druckkammerzentren
- MeiraGTx
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (12)